Question 1

What does Bristol-Myers Squibb do?

Accepted Answer

Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.

Question 2

In what sectors does Bristol-Myers Squibb operate?

Accepted Answer

Bristol-Myers Squibb operates in Biotechnology, Health Care, Medical, Pharmaceutical, Precision Medicine.

Question 3

How many companies has Bristol-Myers Squibb acquired?

Accepted Answer

Bristol-Myers Squibb has made 23 acquisitions between 2001-2025, with a total disclosed deal value of $128.2B.

Question 4

How many acquisitions does Bristol-Myers Squibb make in a year?

Accepted Answer

Over the last 5 years, Bristol-Myers Squibb has made about 1.2 acquisitions per year.

Question 5

What companies are owned by Bristol-Myers Squibb?

Accepted Answer

Companies acquired by Bristol-Myers Squibb include Orbital Therapeutics, 2seventy bio, RayzeBio, Karuna Therapeutics, Mirati Therapeutics, Turning Point Therapeutics, MyoKardia, Forbius, and 15 more.

Question 6

What are Bristol-Myers Squibb's major acquisitions?

Accepted Answer

Bristol-Myers Squibb's largest acquisitions include Celgene ($74.0B, 2019), Karuna Therapeutics ($14.0B, 2023), MyoKardia ($13.1B, 2020), Amylin Pharmaceuticals ($5.3B, 2012).

Question 7

What is Bristol-Myers Squibb's largest acquisition?

Accepted Answer

Bristol-Myers Squibb's largest disclosed acquisition is Celgene for $74.0B (2019).

Question 8

What was Bristol-Myers Squibb's first acquisition?

Accepted Answer

Bristol-Myers Squibb's first recorded acquisition was DuPont Pharmaceuticals in 2001.

Question 9

What was Bristol-Myers Squibb's most recent acquisition?

Accepted Answer

Bristol-Myers Squibb's most recent acquisition is Orbital Therapeutics, announced October 2025 for $1.5B.

Question 10

What is the average deal size for Bristol-Myers Squibb acquisitions?

Accepted Answer

The average disclosed deal size for Bristol-Myers Squibb acquisitions is $7.1B.

Question 11

What is the median deal size for Bristol-Myers Squibb acquisitions?

Accepted Answer

The median disclosed deal size for Bristol-Myers Squibb acquisitions is $1.8B. The median is often lower than the average because a few very large deals pull the average up.

Question 12

How much has Bristol-Myers Squibb spent on acquisitions?

Accepted Answer

Bristol-Myers Squibb has spent at least $128.2B across its disclosed acquisitions (of 23 total deals; some prices are undisclosed).

Question 13

Which sector has Bristol-Myers Squibb spent the most on?

Accepted Answer

Bristol-Myers Squibb has committed the most disclosed capital to Biotechnology companies — about $113.3B across its deals in that sector.

Question 14

What sectors does Bristol-Myers Squibb usually acquire in?

Accepted Answer

Bristol-Myers Squibb most frequently acquires companies in Biotechnology, Health Care, Therapeutics.

Question 15

In which sector has Bristol-Myers Squibb made the most acquisitions?

Accepted Answer

Bristol-Myers Squibb has made the most acquisitions in the Biotechnology sector.

Question 16

In which year did Bristol-Myers Squibb make the most acquisitions?

Accepted Answer

Bristol-Myers Squibb made the most acquisitions in 2023, with 3 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Bristol-Myers Squibb

Company Details

Funding & Financials

Web Traffic

Investor Activity

Company Info

Investments by Bristol-Myers Squibb

Acquisitions by Bristol-Myers Squibb

Explore 200,000+ acquisitions — free

Recent News related to Bristol-Myers Squibb

FAQs about Bristol-Myers Squibb

People who checked this page also checked these